Position in XGN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$98,268
-$7,322,092 QoQ
Shares Held
21,133
-96.9% QoQ
Ownership
0.087%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#36
of 57 holders
Holding Since
Sep 2025
2 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in XGN Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Invesco Ltd. holds $10,733,207,129 across 32 Diagnostics & Research names. XGN ranks #31 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | IDXX |
Idexx Laboratories Inc /De
|
3,611,416 | $1,901,193,829 | |
| 2 | WAT |
Waters Corp /De/
|
3,494,267 | $1,310,489,889 | |
| 3 | TMO |
Thermo Fisher Scientific Inc.
|
2,179,010 | $1,092,468,443 | |
| 4 | ICLR |
Icon PLC
|
5,264,236 | $914,450,430 | |
| 5 | DHR |
Danaher Corp /De/
|
3,955,992 | $753,537,347 | |
| 6 | CRL |
Charles River Laboratories International, Inc.
|
2,984,785 | $676,919,383 | |
| 7 | GH |
Guardant Health, Inc.
|
4,429,755 | $664,596,135 | |
| 8 | IQV |
Iqvia Holdings Inc.
|
3,275,141 | $632,822,736 |
All Filings in XGN
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $98,268 | 21,133 | Shares | Defined | 2026-08-14 | |
| 2025-09-30 | $7,420,360 | 675,192 | Shares | Defined | 2025-11-13 | |
| No filing history on record for this holder in this stock. | ||||||